Healthcare providers continue to adopt AI at a rapid rate, with a majority reporting that they have increased their tech spending over the past year. The new generation of healthcare AI innovation ...

Schizophrenia is currently treated with older medications with limited efficacy and troublesome side effects that lead many patients to stop taking them. The FDA has approved a novel Bristol Myers ...

Although health systems have seen some much-needed improvement to operating margins in recent quarters, these positive headlines mask a disturbing reality that illustrates the immense challenges ...

Maternity care company Pomelo Care has acquired The Doula Network, the companies announced on Tuesday. Traditionally offering only virtual care, the acquisition now allows Pomelo Care to provide ...

This week, a New York City-based startup decided to wage its own David vs. Goliath-style battle in the healthcare technology world. The payer platform space refers to the emerging market for ...

Talkiatry is now the exclusive telepsychiatry provider for BetterHelp’s employer clients, the companies shared with MedCity News exclusively. New York City-based Talkiatry offers online ...

Interest in metabolic medicines is riding high, led by the popular class of weight management drugs known as GLP-1 agonists. BioAge Labs aims to help those medications work better with a lead drug ...

In the midst of budget planning season, businesses are confronted with the looming challenge of managing healthcare costs, a significant line item in their budgets. Reports from the Business Group ...

As health systems work to improve patient outcomes, health equity initiatives offer great promise for meaningful change. But there isn’t a one-size-fits-all solution for addressing the ...

Dr. Timothy Showalter is a radiation oncologist and chief medical officer at AI company Artera. In the last episode of this season — which focuses on AI and Generative AI — Showalter talks ...

Healthcare AI startup Qure.ai closed a $65 million Series D financing round on Wednesday. The startup — which is headquartered in India — plans to use the capital to expand its presence in the ...

Biotech companies with novel molecules in clinical development require substantial sums of cash to finance that research. While venture capital firms continue to raise new funds to deploy across ...